ArticleOncology reports2019

IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.

Xiangrong Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.